Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Screeners that run automatically... and then email you the results! FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

F-Star Therapeutics Inc (FSTX)

F-Star Therapeutics Inc (FSTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 141,401
  • Shares Outstanding, K 21,588
  • Annual Sales, $ 21,170 K
  • Annual Income, $ -31,280 K
  • 60-Month Beta 1.00
  • Price/Sales 6.73
  • Price/Cash Flow N/A
  • Price/Book 1.61
Trade FSTX with:

Options Overview Details

View History
  • Implied Volatility 104.50% ( -3.14%)
  • Historical Volatility 16.53%
  • IV Percentile 46%
  • IV Rank 11.42%
  • IV High 832.63% on 05/10/22
  • IV Low 10.64% on 03/07/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 165
  • Put/Call OI Ratio 2.49
  • Today's Open Interest 6,363
  • Open Int (30-Day) 6,661

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.62
  • Number of Estimates 4
  • High Estimate -0.51
  • Low Estimate -0.73
  • Prior Year -0.92
  • Growth Rate Est. (year over year) +32.61%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.05 +11.07%
on 07/15/22
6.74 -0.30%
on 08/10/22
+0.48 (+7.69%)
since 07/08/22
3-Month
2.07 +224.64%
on 05/12/22
6.74 -0.30%
on 08/10/22
+4.28 (+175.41%)
since 05/10/22
52-Week
2.07 +224.64%
on 05/12/22
8.36 -19.62%
on 09/23/21
+0.90 (+15.46%)
since 08/10/21

Most Recent Stories

More News
invoX Pharma Extends Tender Offer to Acquire F-star Therapeutics, Inc.

invoX Pharma Limited (“invoX”) , a wholly owned subsidiary of Sino Biopharmaceutical Limited (“Sino Biopharm”) (HKEX 1177 HK) , focused on research and development (R&D) and business development...

FSTX : 6.69 (+2.14%)
SHAREHOLDER ALERT: Weiss Law Reminds FSTX, STCN, GRRB, and ZEN Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

FSTX : 6.69 (+2.14%)
STCN : 1.3500 (unch)
ZEN : 76.19 (+0.12%)
F-star Therapeutics Announces a License Agreement with Takeda for a Novel Next-Generation Immuno-oncology Bispecific Antibody

CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., July 20, 2022 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX) (“F-star”), operating...

FSTX : 6.69 (+2.14%)
F-STAR THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of F-star Therapeutics, Inc. - FSTX

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of F-star Therapeutics, Inc. (NasdaqCM: FSTX)...

FSTX : 6.69 (+2.14%)
Best Momentum Stocks to Buy for July 15th

CVLG, FTSX and CVBF made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 15, 2022.

CVBF : 26.83 (+0.64%)
CVLG : 32.79 (+2.69%)
FSTX : 6.69 (+2.14%)
New Strong Buy Stocks for July 15th

GIL, PBR, CVLG, FSTX and CVBF have been added to the Zacks Rank #1 (Strong Buy) List on July 15, 2022.

PBR : 15.52 (+0.52%)
CVBF : 26.83 (+0.64%)
GIL : 31.50 (+3.01%)
CVLG : 32.79 (+2.69%)
FSTX : 6.69 (+2.14%)
H.C. Wainwright Sticks to Its Hold Rating for F-star Therapeutics (FSTX)

H.C. Wainwright analyst Patrick Trucchio maintained a Hold rating on F-star Therapeutics (FSTX – Research Report) today and set a price target of $7.00. The company's shares closed last Thursday at $6.14....

FSTX : 6.69 (+2.14%)
FSTX STOCK ALERT: Halper Sadeh LLP Is Investigating Whether the Sale of F-star Therapeutics, Inc. Is Fair to Shareholders

Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of F-star Therapeutics, Inc. (NASDAQ: FSTX) to invoX Pharma for $7.12 per share is fair to F-star shareholders.

FSTX : 6.69 (+2.14%)
SHAREHOLDER ALERT: Weiss Law Reminds FSTX, STCN, GRRB, and OBCI Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

FSTX : 6.69 (+2.14%)
STCN : 1.3500 (unch)
OBCI : 13.03 (-0.08%)
Best Momentum Stocks to Buy for July 12th

CCBG, IMCR and FSTX made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 12, 2022.

CCBG : 32.98 (+0.52%)
FSTX : 6.69 (+2.14%)
IMCR : 54.60 (+5.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

F-star Therapeutics Inc. is a clinical-stage biopharmaceutical company. It engages in developing tetravalent bispecific antibodies for a paradigm-shift in cancer therapy. F-star Therapeutics Inc., formerly known as Spring Bank Pharmaceuticals Inc., is based in CAMBRIDGE, Mass.

See More

Key Turning Points

3rd Resistance Point 6.79
2nd Resistance Point 6.72
1st Resistance Point 6.63
Last Price 6.69
1st Support Level 6.47
2nd Support Level 6.40
3rd Support Level 6.31

See More

52-Week High 8.36
Last Price 6.69
Fibonacci 61.8% 5.96
Fibonacci 50% 5.21
Fibonacci 38.2% 4.47
52-Week Low 2.07

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar